Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia

<p>Dr Jacob D Soumerai and Prof Andrew D Zelenetz discuss their phase 2 trial of the BOVen regimen and MRD-driven treatment discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00307-0/fulltext'>https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00307-0/fulltext</a> </p>